Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Austin Partnership Provides New Options to Patients Being Treated for Depression, Anxiety, and PTSD

Kalypso Wellness Center and CARMAhealth Bring Kalypso's Patent-Pending Ketamine Treatment to Central Plains Region


News provided by

Kalypso Wellness Center

Jun 11, 2020, 06:00 ET

Share this article

Share toX

Share this article

Share toX


AUSTIN, June 11, 2020 /PRNewswire-PRWeb/ -- Kalypso Wellness Centers, one of the nation's leading providers of ketamine infusions, has partnered with CARMAhealth to bring Kalypso's patent-pending ketamine treatments to some patients being treated for depression, anxiety, and PTSD at CARMAhealth's Central Austin location.

Kalypso has successfully treated patients from more than 32 different disease states. As ketamine becomes a more accepted and widely used form of treatment for these disorders, the number of ketamine clinics nationwide continues to grow and is currently estimated at more than 300. However, Kalypso is one of only a handful of companies with multiple locations. The Central Austin clinic is the 10th managed location (6 in Texas and one each in New York, North Carolina, Mississippi and Pennsylvania) to offer Kalypso's revolutionary ketamine treatments.

What sets Kalypso’s ketamine low-dose treatments apart from those offered elsewhere is their use of five distinct proprietary ketamine formulations to create an individualized approach to the patient’s symptoms.

Post this

A big reason why ketamine use in the medical industry is becoming more widespread is due to its high success rate. Kalypso reports that more than 90% of their patients experienced positive results, with less than 5% of patients experiencing any adverse reactions. Both of these percentages are well ahead of the national average. Kalypso and CARMAhealth expect this trend to continue at the Central Austin location.

"We have been monitoring the success of ketamine infusion around the country for many years, and the clinicians at CARMA have been interested in offering this service," said Dr. Steven Powell, Medical Director at CARMAhealth. "The profound beneficial effect that ketamine has on depression and PTSD is very impressive. We are excited to be able to recommend this safe and effective treatment to our patients who would benefit."

What sets Kalypso's ketamine low-dose treatments apart from those offered elsewhere is their use of five distinct proprietary ketamine formulations to create an individualized approach to the patient's symptoms. Kalypso's approach to the treatment process has resulted in remarkable success through more than 7,500 ketamine infusions since founded in 2016.

Ketamine therapy is an in-office procedure. CARMAhealth has been taking steps to ensure the safety of our staff and clients during the COVID-19 pandemic including prescreening all clients prior to entry to the clinic, converting most non-infusion visits to telehealth and staggering in-office visits to minimize contact in the waiting room, sanitizing all procedure rooms between appointments, and of course implementing standard precautions including masks, gloves, and gowns for our staff and patients and readily available hand and surface sanitizers.

"This partnership with CARMAhealth is the next step in our expansion to bring our unique ketamine treatments to those who are suffering," said Dr. Cannon Clifton, Kalypso Wellness Center's CEO and Co-Founder. "We could not have found a more effective partner for this expansion than CARMAhealth, with all the work they've done to care for patients with, depression and anxiety. The clear winners here are the patients in Austin and the surrounding areas. When they come to this location, they are going to receive the best possible treatment and see amazing results."

About Kalypso Wellness Centers
Kalypso Wellness Centers was formed in 2016 by two board-certified anesthesiologists, Dr. Cannon Clifton, CEO and Dr. Bryan Clifton, CMO; and two board certified pain management physicians, Dr. Mark Moran, Chief Science Officer and Dr. Scott Worrich, Chief Clinical Officer. They were tired of seeing patients needlessly suffering and chronically debilitated on prescription narcotics. After many months of research, they found a promising new solution with the use of ketamine infusions. As treatments continued, they created the RESET Ketamine Therapy®, which includes five distinct proprietary ketamine formulations: Kalypso-Calm®, KalyCan®, KalyMax®, Kalypso-Pro® and Kalypso-Zen®. Upon further investigation, they discovered that when tailored to each patient's unique disease state, these infusions can provide a substantial improvement in quality of life for patients with anxiety, major depressive disorder, PTSD, bipolar disorder, fibromyalgia, neuropathic pain, inflammatory pain, chronic pain, and migraines/chronic headaches. For more information, visit http://www.kalypsowellness.com. For patient testimonials, visit https://www.kalypsowellness.com/about/testimonials/.

About CARMAhealth
CARMAhealth is a full-service healthcare provider with locations in Austin and Dripping Springs, TX providing comprehensive primary and psychiatric care for individuals with substance use disorder. Our team of specialized doctors, nurse practitioners, and mental health professionals provide stigma-free, evidence-based care to individuals in all stages of addiction, including withdrawal management, medication-assisted treatment, and primary and psychiatric medical care. CARMAhealth providers view addiction as a chronic condition that responds to treatment and improves over time and employ science and data in setting the standard for addiction medicine. For more information, visit http://www.carmahealth.com.

SOURCE Kalypso Wellness Center

Related Links

http://www.kalypsowellness.com

Modal title

1 800 RESET 20
1 800 RESET 20
David Kramer, MD, Medical Director
David Kramer, MD, Medical Director
1 800 RESET 20 David Kramer, MD, Medical Director

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.